GDERF Q1 sales growth and FY26 outlook confirmation

What happened: Galderma (GDERF) reported Q1 sales growth, with all segments improving, and confirmed its FY26 outlook of 17-20% net sales growth and a Core EBITDA margin of 27-29%. Coca-Cola Europacific Partners (CCEP) saw Q1 revenue and volume rise, with growth in all regions except Southeast Asia, reaffirming its FY26 guidance. Fraport (FRA.DE) reported a wider Q1 group loss but increased EBITDA and revenues, maintaining its FY26 outlook.

Market impact: These companies' positive outlooks and performance signals boosted investor confidence in the consumer goods and services sector. Galderma's skincare segment growth may benefit competitors like L'Oréal (OR.PA) and Estée Lauder (EL.N), while CCEP's regional growth could impact other beverage companies like Nestlé (NESN.SW) and PepsiCo (PEP.N). Fraport's performance may influence other airport operators like Vinci (DG.PA) and Ferrovial (FER.MC).

What to watch next: Galderma's FY26 guidance will be tested in upcoming quarters. CCEP's performance in Southeast Asia will be closely watched, as will its ability to maintain growth in other regions. For Fraport, the evolution of travel demand and its impact on airport traffic will be crucial. Upcoming earnings reports from these companies and their peers will provide further insights.